UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is pleased to announce the recipients of the 2017 Pilot Project awards. Fifteen projects were selected in four categories, including Clinical Research, Innovative Technology Research, Academic-Community Partnership Research, and Dissemination and Implementation Research. Pilot Project grants are one-year competitive cash awards for researchers to obtain preliminary data.
“This year’s pilot projects demonstrate a range of research topics, including a new therapy for Zika virus, robot-assisted biopsy forceps for flexible endoscopy, and the role of mothers’ placentas in their child’s weight and related comorbidities,” said Murray B. Stein, MD, MPH, co-director of the ACTRI Pilot Project Program. “We were truly impressed with the quality of the applicants.”
The awardees are from UC San Diego and San Diego State University (SDSU). At UC San Diego they represent six departments, the School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences, and the Jacobs School of Engineering; at SDSU investigators represent two departments.
Academic-Community Partnership pilots include community partners and one project has a co-investigator from Azusa Pacific University. “Through this successful partnership program, we continue to reach out to the community, strengthen collaborations between UC San Diego, SDSU and other ACTRI partners, and involve community organizations while addressing critical concerns,” said Howard Taras, MD, director of the ACTRI Community Engagement unit and creator of the Academic-Community partnership pilot project program.
Shelia Broyles, PhD, MPH, ACTRI Community Engagement faculty liaison and Community Engagement Pilot Grant Program director, oversees the selection of the community pilot programs.
The funding period is April 1, 2017 through March 31, 2018.
Click here to view the new Pilot Project recipients and their research project abstracts.
About UC San Diego Altman Clinical and Translational Research Institute:
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.